MDCG 2024-3 医疗器械临床试验临床试验计划内容指南
VIP免费
MDCG 2024-3
Medical Device Coordination Group Document
Medical Device
MDCG 2024-3
2024 3
2017/745 103
MDCGMDCG
1
MDCG 2024-3
Medical Device Coordination Group Document
Medical Device
2
MDCG 2024-3
Medical Device Coordination Group Document
Medical Device
............................................................................................................................................................................................. 4
1. .........................................................................................................................................................................................5
2. CIP ..............................................................................................................................................................................6
3. CIP ..............................................................................................................................................................................6
3.1. ............................................................................................................................................................................. 6
3.2. ......................................................................................................................................... 7
3.3. 8
3.3.1. ..............................................................................................................................................................................8
3.3.2. ..............................................................................................................................................................................9
3.3.3. ............................................................................................................................................................... 10
3.4. ....................................................................................................................................................10
3.5. ............................................................................................................................................................... 11
3.6. ....................................................................................................................................................... 11
3.6.1.
................................................................................................................................11
3.6.2.
............................................................................................................................................................................................... 12
3.6.3.
............................................................................................12
3.6.4.
................................................................................................................................................................... 13
3.6.5.
........................................................................................................... 13
3.6.6. ................................................................................................................................................................... 14
3.7. .........................................................................................................................................................15
3.8. ................................................................................................................................................................... 16
3.9. CIP .................................................................................................................................................................16
3.10. CIP ........................................................................................................................................................17
3.11. ................................................................................................................................................................... 17
3.12. ................................................................................................................................................................... 17
3.13. ........................................................................................................................................................... 18
3.14. ................................................................................................................... 18
3.15. ....................................................................................................................... 19
3.16. ................................................................................................................................................... 20
3.17. ................................................................................................................................................................... 20
3.18. ........................................................................................................................................... 20
3.19. .....................................................................................................................................................................20
3
摘要：
展开>>
收起<<
MDCG20243MedicalDeviceCoordinationGroupDocumentMedicalDeviceMDCG20243SuVhhN4N4RQcSW2024t3ggeNu1kv2017745Sl103gazvSuVhhSOMDCGS0MDCGu1bgbTXVvNhbu1kvYTXOvNTNhbNN0geNvkvYTXOeNNNSfkvYTXOvezW0geNNhvNOUpWGNQwglgRSgkvlbYkvlOQQwggRv01MDCG20243MedicalDeviceCoordinationGroupDocumentMedicalDevice2MDCG20243Medic...
声明：如果您的权利被侵害，请联系我们的进行举报。
相关推荐
-
YY 1042-2023 牙科学 聚合物基修复材料VIP免费
2024-04-11 145 -
YY∕T 1465.1-2016 医疗器械免疫原性评价方法 第1部分：体外T淋巴细胞转化试验VIP免费
2024-04-15 207 -
YY∕T 1465.2-2016 医疗器械免疫原性评价方法 第2部分：血清免疫球蛋白和补体成分测定（ELISA法）VIP免费
2024-04-15 97 -
YY∕T 1465.3-2016 医疗器械免疫原性评价方法 第3部分：空斑形成细胞测定琼脂固相法VIP免费
2024-04-15 152 -
YY∕T 1789.2-2021 体外诊断检验系统性能评价方法 第2部分：正确度
2024-10-07 293 -
YY∕T 1789.1-2021 体外诊断检验系统性能评价方法 第1部分：精密度
2024-10-07 538 -
YY∕T 1789.6-2023体外诊断检验系统 性能评价方法 第6部分：定性试剂的精密度、诊断灵敏
2024-10-07 200 -
YY∕T 1789.4-2022 体外诊断检验系统 性能评价方法 第4部分：线性区间与可报告区间
2024-10-07 295 -
YY∕T 1789.3-2022 体外诊断检验系统 性能评价方法 第3部分：检出限与定量限
2024-10-07 230 -
YY∕T 1789.5-2023 体外诊断检验系统 性能评价方法 第5部分：分析特异性
2024-10-07 245
作者：一如既往
分类：法规规范
价格：120质量币
属性：21 页
大小：2.02MB
格式：PDF
时间：2026-03-17
